Variation in EGFR testing for patients with stage IB or higher lung cancer in the United States.
- DOI
- 10.1080/17520363.2026.2737285
- Published
- 2026 Sep 24
- Container
- Biomarkers in medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17520363.2026.2737285,
title = {Variation in EGFR testing for patients with stage IB or higher lung cancer in the United States.},
author = {Odeh B and Pohlman A and Albain KS and Sethakorn N and Harkenrider MM and Coughlin JM and Abdelsattar ZM},
year = {2026},
journal = {Biomarkers in medicine},
doi = {10.1080/17520363.2026.2737285},
url = {https://doi.org/10.1080/17520363.2026.2737285}
}RIS
TY - JOUR TI - Variation in EGFR testing for patients with stage IB or higher lung cancer in the United States. AU - Odeh B AU - Pohlman A AU - Albain KS AU - Sethakorn N AU - Harkenrider MM AU - Coughlin JM AU - Abdelsattar ZM PY - 2026 JO - Biomarkers in medicine DO - 10.1080/17520363.2026.2737285 UR - https://doi.org/10.1080/17520363.2026.2737285 ER -
APA
B, O., A, P., KS, A., N, S., MM, H., JM, C., & ZM, A. (2026). Variation in EGFR testing for patients with stage IB or higher lung cancer in the United States.. Biomarkers in medicine. https://doi.org/10.1080/17520363.2026.2737285
Source records
- pubmed · retrieved 2026-09-26T02:31:15.746Z